Quality improvement project for prevention of infusion related reactions of daratumumab therapy in multiple myeloma patients

被引：0
|
作者：
Jindal, Vishal [1 ]
Shepro, David Scott [1 ]
Pranckevicius, Leigh [1 ]
Siddiqui, Ahmad Daniyal [1 ]
机构：
[1] St Vincent Hosp, Worcester, MA 01604 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18877
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18877
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ACCELERATED INFUSION OF DARATUMUMAB IS SAFE IN MULTIPLE MYELOMA PATIENTS
    Jak, M.
    Oostvogels, R.
    Minnema, M. C.
    HAEMATOLOGICA, 2018, 103 : 20 - 20
  • [2] DARATUMUMAB INFUSION IN 90 MINUTES IN PATIENTS WITH MULTIPLE MYELOMA
    Alfayate, Lobo Ana
    Inigo, Rodriguez Maria Belen
    Cubillas, Garcia De la Torre Damian
    Menendez, Cuevas Marina
    Colas, Lahuerta Blanca
    Calo, Perez Aida
    Gomez, Alvarez Miguel
    Estival, Monteliu Pablo
    Escribano, Serrat Silvia
    Gulino, Martin Horacio
    Medina, Salazar Sissy Fiorella
    Bolanos, Calderon Estefania
    Perez, Lopez Cristina
    Pena, Cortijo Ascension
    Polo, Zarzuela Marta
    Mateo, Morales Marta
    Benavente, Cuesta Celina Maria
    Daorta, Null Melisa Almendra
    Moreno, Paredes Nahir Daniela
    HAEMATOLOGICA, 2020, 105 : 363 - 364
  • [3] Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab
    Moore, Donald C.
    Arnall, Justin R.
    Thompson, Daniel L.
    Martin, Allison L.
    Robinson, Jordan
    Ndiaye, Ami
    Paul, Barry
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter M.
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : E777 - E781
  • [4] A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting
    Geirnaert, Marc
    Howarth, Jacy
    Martin, Kristen
    Ricard, Chad
    Streilein, Scott
    Wasney, Danica
    Dao, Vi
    Kotb, Rami
    Rimmer, Emily
    Minuk, Leonard
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (04) : 907 - 910
  • [5] Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and Elotuzumab
    Nooka, Ajay K.
    Gleason, Charise
    Sargeant, Marva Ollivierre
    Walker, Michelle
    Watson, Melanie
    Panjic, Elyse Hall
    Lonial, Sagar
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (07) : 414 - +
  • [6] Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma
    Yin, Xi-xi
    Hu, Yueyun
    Yang, Yusi
    Zhang, Xinglan
    Liu, Li
    Cao, Xi
    Chen, Jianwen
    Xia, Zhongjun
    Wang, Ye
    CANCER MEDICINE, 2024, 13 (11):
  • [7] DARATUMUMAB MONOTHERAPY IN REAL LIFE COMMUNITY SETTING OF REFRACTORY MYELOMA PATIENTS: COMFORTABLE MANAGEMENT OF INFUSION-RELATED REACTIONS AT THE FIRST INFUSION
    Parisi, M.
    Del Fabro, V.
    Martino, E.
    Calafiore, V.
    Sapienza, G.
    Leotta, V.
    Parrinello, N. L.
    Triolo, A.
    Romano, A.
    Conticello, C.
    Di Raimondo, F.
    HAEMATOLOGICA, 2018, 103 : S84 - S84
  • [8] Ninety-minute daratumumab infusion is safe in multiple myeloma
    Hallie Barr
    Jessica Dempsey
    Allyson Waller
    Ying Huang
    Nita Williams
    Nidhi Sharma
    Don M. Benson
    Ashley E. Rosko
    Yvonne A. Efebera
    Craig C. Hofmeister
    Leukemia, 2018, 32 : 2495 - 2518
  • [9] SAFETY OF RAPID DARATUMUMAB INFUSION IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Attardi, E.
    Antonioli, E.
    Staderini, M.
    Messeri, M.
    Buzzichelli, A.
    Nencini, V.
    Fani, A.
    Bosi, A.
    HAEMATOLOGICA, 2019, 104 : 65 - 66
  • [10] Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma
    Barr, Hallie
    Dempsey, Jessica
    Waller, Allyson
    Huang, Ying
    Williams, Nita
    Sharma, Nidhi
    Benson, Don M., Jr.
    Rosko, Ashley E.
    Efebera, Yvonne A.
    Hofmeister, Craig C.
    BLOOD, 2017, 130
12345